Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Case report: dose adjustment of warfarin using genetic information and plasma concentration monitoring.

Journal of clinical pharmacy and therapeutics - 1 Jun 2014

Aomori T, Fujita Y, Obayashi K, Sato H, Kiyotani K, Nakamura K, Nakamura T, Yamamoto K

Abstract excerpt

WHAT IS KNOWN AND OBJECTIVE: Carbamazepine is known to interact with warfarin. We report on a case of this interaction and on its management using the patient's genetic information. CASE SUMMARY: The case concerns a 74-year-old Japanese woman with a mood disorder and a central retinal vein occlusion. She was on therapy that included carbamazepine and had started to take warfarin. However, the patient's...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Anticoagulants
Share to Carbamazepine

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genotype

Share to International Normalized Ratio

Share to Pharmacogenetics

Share to Vitamin K Epoxide Reductases

Share to Warfarin

Source

Identifiers

PMID: 24612117
DOI: 10.1111/jcpt.12135

Genes

VKORC1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Case report: dose adjustment of warfarin using genetic information and plasma concentration monitoring.PMID 24612117Read ↗

Integrating genomic based information into clinical warfarin (Coumadin) management: an illustrative case report.Semantic proximity Read ↗

An instructive case suggesting warfarin resistance which is independent on the regulation of the CYP2C9 and VKORC1 genotype.Semantic proximity Read ↗

[Challenge in genome-wide association study for establishment of personalized medicine: focusing on the pharmacogenomics of warfarin and carbamazepine].Semantic proximity Read ↗

Variations in prothrombin time-international normalized ratio caused by drug-drug interaction in patients receiving warfarin: A retrospective observational study.Semantic proximity Read ↗

An algorithm for managing warfarin resistanceSemantic proximity Read ↗

A mysterious resistance to acenocoumarol!Semantic proximity Read ↗

Effect of CYP3A5 genotypes on the pharmacokinetics of carbamazepine when used as monotherapy or co-administered with phenytoin, phenobarbital or valproic acid in Thai patients.Semantic proximity Read ↗

Influence of CYP2C9 polymorphism and phenytoin co-administration on acenocoumarol dose in patients with cerebral venous thrombosis.Semantic proximity Read ↗

Acenocoumarol and phenytoin toxicity in the presence of CYP2C9 mutation.Semantic proximity Read ↗

CYP4F2 gene polymorphism as a contributor to warfarin maintenance dose in Japanese subjects.Semantic proximity Read ↗

A case report of a patient carrying CYP2C9*3/4 genotype with extremely low warfarin dose requirement.Semantic proximity Read ↗

Presence of allele CYP3A4*16 does not have any bearing on carbamazepine-induced adverse drug reactions in North Indian people with epilepsy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.